Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | SYN004 |
Synonyms | |
Therapy Description |
SYN004 is a monoclonal antibody that binds to and inhibits EGFR signaling, leading to potential anti-tumor activity (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SYN004 | EGFR Antibody 56 | SYN004 is a monoclonal antibody that binds to and inhibits EGFR signaling, leading to potential anti-tumor activity (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02391727 | Phase I | SYN004 | Safety, Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid Tumors (SYN004_Ph_1) | Completed | USA | 0 |